天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

廣州佳途科技股份有限公司 Company Information
Company Name:    Cato Research Chemicals Inc.
Tel:    020-81960175
Email:    3008394369@qq.com
Nationality:    China
WebSite:    www.cato-chem.com/
Product List:    15726
122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158
Product List
Obeticholic Acid impurity 36 1834605-28-5
Sildenafil Impurity 82 139756-30-2
Sildenafil Impurity 47 944241-52-5
Palbociclib Impurity 114 412348-27-7
Palbociclib Impurity 109 1974279-20-3
Sorafenib (Base) 284461-73-0
Sorafenib Impurity 22 583840-03-3
Canagliflozin Impurity 56
Ivabradine Impurity 12 304464-97-9
Epirubicin EP Impurity D 20830-81-3
Esomeprazole Impurity 17 151602-49-2
Risperidone EP Impurity I 1329796-66-8
Risperidone EP Impurity H 158697-67-7
Citalopram Impurity 13 85118-25-8
Agomelatine Impurity 39 144705-51-1
Pramipexole Impurity 43 1001648-75-4
Pramipexole Impurity 42 1797134-75-8
Palonosetron Impurity 30 1227162-74-4
Palonosetron Impurity 13 2216753-67-0
Linagliptin Impurity 18 668273-74-3
Ezetimibe Impurity 86 1650568-82-3
Azilsartan Impurity 96 1985638-55-8
Azilsartan Impurity 95 57113-90-3
Azilsartan Impurity 94 209551-67-7
Azilsartan Impurity 93 1800532-35-7
Azilsartan Impurity 84 1514933-24-4
Azilsartan Impurity 80 136285-66-0
Azilsartan Impurity 63 985638-55-8
Azilsartan Impurity 25 1584730-02-8
Azilsartan Impurity 19 1993494-84-0
Ticagrelor-d7 1265911-55-4
Ticagrelor Impurity 72 Mandelate
Ticagrelor Impurity 66 HCl
Ticagrelor Impurity 65 HCl
Ticagrelor Impurity 50 1314324-00-9
Ticagrelor impurity 156 1415905-52-0
Ticagrelor Impurity 155 1482484-62-7
Ezetimibe Impurity 65 1185883-39-9
Brexpiprazole Impurity 87 62969-59-9
Amoxicillin Impurity 49 57591-61-4
Sitagliptin Impurity 18 922178-94-7
Sitagliptin Impurity 107 89124-06-1
Aprepitant Impurity 41 502537-39-5
rac-Aprepitant-d4 (and enantiomer)
Plerixafor Impurity 4
Atorvastatin Epoxy Pyrrolooxazin Tricyclic Sodium Salt
Ticagrelor Impurity 115 1823431-32-8
Poricoic acid A 137551-38-3
VcMMAE 646502-53-6
morpholine-3,5-dione 4430-05-1
Clevidipine butyrate Impurity 3 253597-19-2
Bicalutamide Impurity 6
Bicalutamide Impurtiy 21 71515-96-3
Bicalutamide Impurtiy 19 50986-83-9
Oxiracetam Impurity 21 85153-60-2
Acyclovir Impurity O 2190509-40-9
Apremilast Impurity 38 2095036-40-9
Argatroban Impurity 140 HCl
Clarithromycin Impurity 22
methyl N-(3-methoxy-3-oxopropyl)-N-methyl-beta-alaninate 105-71-5
Desmycosin 11032-98-7
Methylboronic Acid-d3 1332481-37-4
2'-Deoxyadenosine monohydrate 16373-93-6
Escin 6805-41-0
Sodium Phenyl Phosphate Dibasic Dihydrate 66778-08-3
Celecoxib Impurity 39 6034-55-5
Donepezil Desbenzyl Impurity 120013-39-0
Ranolazine 95635-55-5
Vonoprazan Fumarate Impurity 21
Enzalutamide Impurity 5 179232-29-2
Enzalutamide Impurity 32 1839619-50-9
Revefenacin Impurity 40 39546-32-2
Bortezomib Impurity 18 1132709-16-0
Axitinib Impurity 12
Erlotinib Impurity 92 183321-86-0
Erlotinib Hydrochloride 183319-69-9
Edoxaban Impurity 97 (Mixture of Diastereomers)
Bromhexine 3572-43-8
Vortioxetine Impurity 95 1446750-99-7
Vortioxetine Impurity 77 88-61-9
Topiroxostat Impurity 21
Solifenacin EP Impurity G HCl 180468-37-5
Sofosbuvir Impurity 68 1496551-65-5
Apixaban Impurity 128
Diacerein Impurity 16
Diacerein Impurity 15
Etoricoxib Impurity 28 5470-70-2
Tofacitinib Impurity 56 923036-30-0
Tofacitinib Impurity 4 477600-73-0
Moxifloxacin Impurity 118 1395056-42-4
Moxifloxacin 151096-09-2
Bortezomib Impurity 17 1194235-41-0
Apixaban Impurity 20 1267610-26-3
Ticagrelor Impurity 107 155899-66-4
Apixaban Impurity 30 1686149-78-9
Lurasidone Impurity 53 HCl 1318074-27-9
Tadalafil Impurity 90 1978323-00-0
Vonoprazan Impurity 157 2514735-09-0
3-Methyl-4-heptanol 1838-73-9
Ticagrelor Impurity 76 (Mixture of Diastereomers)
122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158
Copyright 2007©  ChemicalBook. All rights reserved.